DME Capital Management’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Hold |
566,130
| – | – | 0.04% | 31 |
|
|
2025
Q1 | $1.08M | Hold |
566,130
| – | – | 0.05% | 30 |
|
|
2024
Q4 | $1.22M | Hold |
566,130
| – | – | 0.06% | 33 |
|
|
2024
Q3 | $1.01M | Hold |
566,130
| – | – | 0.04% | 34 |
|
|
2024
Q2 | $725K | Hold |
566,130
| – | – | 0.04% | 36 |
|
|
2024
Q1 | $2.13M | Buy |
+566,130
| New | +$2.13M | 0.1% | 34 |
|